These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Immunogenicity and protective efficacy of candidate universal influenza A nanovaccines produced in plants by Tobacco mosaic virus-based vectors. Petukhova NV; Gasanova TV; Stepanova LA; Rusova OA; Potapchuk MV; Korotkov AV; Skurat EV; Tsybalova LM; Kiselev OI; Ivanov PA; Atabekov JG Curr Pharm Des; 2013; 19(31):5587-600. PubMed ID: 23394564 [TBL] [Abstract][Full Text] [Related]
27. Preclinical studies of targeted therapies for CD20-positive B lymphoid malignancies by Ofatumumab conjugated with auristatin. Li ZH; Zhang Q; Wang HB; Zhang YN; Ding D; Pan LQ; Miao D; Xu S; Zhang C; Luo PH; Naranmandura H; Chen SQ Invest New Drugs; 2014 Feb; 32(1):75-86. PubMed ID: 23903896 [TBL] [Abstract][Full Text] [Related]
28. Let There Be Light: Targeted Photodynamic Therapy Using High Aspect Ratio Plant Viral Nanoparticles. Chariou PL; Wang L; Desai C; Park J; Robbins LK; von Recum HA; Ghiladi RA; Steinmetz NF Macromol Biosci; 2019 May; 19(5):e1800407. PubMed ID: 30721575 [TBL] [Abstract][Full Text] [Related]
29. Peripheral neuropathy with microtubule inhibitor containing antibody drug conjugates: Challenges and perspectives in translatability from nonclinical toxicology studies to the clinic. Stagg NJ; Shen BQ; Brunstein F; Li C; Kamath AV; Zhong F; Schutten M; Fine BM Regul Toxicol Pharmacol; 2016 Dec; 82():1-13. PubMed ID: 27773754 [TBL] [Abstract][Full Text] [Related]
30. Sortase A-Generated Highly Potent Anti-CD20-MMAE Conjugates for Efficient Elimination of B-Lineage Lymphomas. Pan L; Zhao W; Lai J; Ding D; Zhang Q; Yang X; Huang M; Jin S; Xu Y; Zeng S; Chou JJ; Chen S Small; 2017 Feb; 13(6):. PubMed ID: 27873460 [TBL] [Abstract][Full Text] [Related]
31. Multivalent Display of ApoAI Peptides on the Surface of Tobacco Mosaic Virus Nanotubes Improves Cholesterol Efflux. Shin MD; Ortega-Rivera OA; Steinmetz NF Bioconjug Chem; 2022 Oct; 33(10):1922-1933. PubMed ID: 36191144 [TBL] [Abstract][Full Text] [Related]
32. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. Pérez-Herrero E; Fernández-Medarde A Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885 [TBL] [Abstract][Full Text] [Related]
33. Trastuzumab-monomethyl auristatin E conjugate exhibits potent cytotoxic activity in vitro against HER2-positive human breast cancer. Abdollahpour-Alitappeh M; Lotfinia M; Bagheri N; Sineh Sepehr K; Habibi-Anbouhi M; Kobarfard F; Balalaie S; Foroumadi A; Abbaszadeh-Goudarzi G; Abbaszadeh-Goudarzi K; Abolhassani M J Cell Physiol; 2019 Mar; 234(3):2693-2704. PubMed ID: 30246298 [TBL] [Abstract][Full Text] [Related]
34. Thermal transition of native tobacco mosaic virus and RNA-free viral proteins into spherical nanoparticles. Atabekov J; Nikitin N; Arkhipenko M; Chirkov S; Karpova O J Gen Virol; 2011 Feb; 92(Pt 2):453-6. PubMed ID: 20980527 [TBL] [Abstract][Full Text] [Related]
35. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. Plosker GL; Figgitt DP Drugs; 2003; 63(8):803-43. PubMed ID: 12662126 [TBL] [Abstract][Full Text] [Related]
36. Bioinspired Artificial Tobacco Mosaic Virus with Combined Oncolytic Properties to Completely Destroy Multidrug-Resistant Cancer. Wu H; Zhong D; Zhang Z; Li Y; Zhang X; Li Y; Zhang Z; Xu X; Yang J; Gu Z Adv Mater; 2020 Mar; 32(9):e1904958. PubMed ID: 31961987 [TBL] [Abstract][Full Text] [Related]
37. Tobacco mosaic virus movement protein complements a Potato spindle tuber viroid RNA mutant impaired for mesophyll entry but not mutants unable to enter the phloem. Wu J; Bisaro DM PLoS Pathog; 2022 Dec; 18(12):e1011062. PubMed ID: 36574436 [TBL] [Abstract][Full Text] [Related]
38. Milestones in the research on tobacco mosaic virus. Harrison BD; Wilson TM Philos Trans R Soc Lond B Biol Sci; 1999 Mar; 354(1383):521-9. PubMed ID: 10212931 [TBL] [Abstract][Full Text] [Related]
39. Tobacco mosaic virus (TMV) and potato virus X (PVX) coat proteins confer heterologous interference to PVX and TMV infection, respectively. Bazzini AA; Asurmendi S; Hopp HE; Beachy RN J Gen Virol; 2006 Apr; 87(Pt 4):1005-1012. PubMed ID: 16528051 [TBL] [Abstract][Full Text] [Related]
40. Novel roles for well-known players: from tobacco mosaic virus pests to enzymatically active assemblies. Koch C; Eber FJ; Azucena C; Förste A; Walheim S; Schimmel T; Bittner AM; Jeske H; Gliemann H; Eiben S; Geiger FC; Wege C Beilstein J Nanotechnol; 2016; 7():613-29. PubMed ID: 27335751 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]